MilliporeSigma
Ascentis Express Phenyl-Hexyl, 2.7um HPLC Column, 15 cm x 4.6 mm I.D. (2.7 um particles), 1EA
- SKU:
- 53353-U
On Sale
Description
Ascentis® Express 90 Å Phenyl-Hexyl (2.7 μm) HPLC Columns
L × I.D. 15 cm × 4.6 mm, HPLC Column
Synonym(s):
Core-shell (SPP) Fused Core Phenyl HPLC column
About This Item
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52
Properties
product name
Ascentis® Express Phenyl-Hexyl, 2.7 μm HPLC Column, 2.7 μm particle size, L × I.D. 15 cm × 4.6 mm
material
stainless steel column
Quality Level
100
agency
suitable for USP L11
product line
Ascentis®
feature
endcapped
manufacturer/tradename
Ascentis®
packaging
1 ea of
parameter
60 °C temp. range
600 bar max. pressure (9000 psi)
technique(s)
HPLC: suitable
LC/MS: suitable
UHPLC-MS: suitable
UHPLC: suitable
L × I.D.
15 cm × 4.6 mm
surface area
135 m2/g
impurities
<5 ppm metals
matrix
Fused-Core particle platform
superficially porous particle
matrix active group
phenylhexyl phase
particle size
2.7 μm
pore size
90 Å
pH range
2-9
application(s)
food and beverages
separation technique
reversed phase
Description
General description
The Phenyl-Hexyl phase has unique selectivity arising from solute interaction with the aromatic ring and its delocalized electrons. It is complementary (orthogonal) to both C18 and RP-Amide phases because of this unique aromaticity. The Phenyl-Hexyl phase also tend to exhibit good shape selectivity, which may originate from solute multipoint interaction with the planar ring system. More retention and selectivity will often be observed for solutes with aromatic electron-withdrawing groups (fluorine, nitro, etc.) or with a delocalized heterocyclic ring system such as the benzodiazepine compounds.
Application
- A Different Perspective on the Characterization of a New Degradation Product of Flibanserin With HPLC-DAD-ESI-IT-TOF-MSn and Its Pharmaceutical Formulation Analysis With Inter-Laboratory Comparison.: This study utilizes the Ascentis® Express Phenyl-Hexyl, 2.7 μm HPLC column to characterize degradation products of flibanserin, demonstrating its efficacy in high-resolution analytical applications (Geven et al., 2023).
- HPLC with spectrophotometric or mass spectrometric detection for quantifying very-long chain fatty acids in human plasma and its association with cardiac risk factors.: The Ascentis® Express Phenyl-Hexyl column was employed for precise quantification of fatty acids, linking its use to critical clinical research on cardiac risk factors (Shrestha et al., 2021).
- A fully automated and fast method using direct sample injection combined with fused-core column on-line SPE-HPLC for determination of ochratoxin A and citrinin in lager beers.: This research highlights the efficiency of the Ascentis® Express Phenyl-Hexyl column in detecting contaminants in beverages, emphasizing its role in food safety analysis (Lhotska et al., 2016).
- A study of retention characteristics and quality control of nutraceuticals containing resveratrol and polydatin using fused-core column chromatography.: This study explores the retention characteristics of nutraceuticals using the Ascentis® Express Phenyl-Hexyl column, showcasing its utility in quality control of health supplements (Fibigr et al., 2016).
- An on-line SPE-HPLC method for effective sample preconcentration and determination of fenoxycarb and cis, trans-permethrin in surface waters.: The Ascentis® Express Phenyl-Hexyl column was integral in preconcentrating and analyzing pesticide residues in environmental samples, underscoring its environmental analytical applications (Satinsky et al., 2015).
Legal Information
Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
Safety Information
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable